vaccine

Cuba aspires to vaccinate its entire population

Cuba aspires to vaccinate its entire population

BY: Alexis Bandrich Vega* PEJOURNAL - Soberana 01 has been called the phase I-II clinical trial that will validate the efficacy of the Cuban vaccine candidate against COVID-19, which began to be applied to a group of volunteers on August 24. The works are developed by the Finlay Vaccine Institute, which has more than 30 years of experience in vaccine development and a long history of cooperation with the Pasteur Institute of Iran. Initially, work began with 20 volunteers from two population groups, between 19 and 59 years old and another from 60 to 80, to whom different doses of…
Read More
Large antibody study offers hope for virus vaccine efforts

Large antibody study offers hope for virus vaccine efforts

PEJOURNAL - Antibody that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found. Tuesday’s report, from tests on more than 30,000 people in Iceland, is the most extensive work yet on the immune system’s response to the virus over time, and is good news for efforts to develop vaccines. If a vaccine can spur production of long-lasting antibodies as natural infection seems to do, it gives hope that “immunity to this unpredictable and highly contagious virus may not be fleeting,” scientists…
Read More
This morning, for the first time in the world, a vaccine against the new coronavirus was registered in Russia

This morning, for the first time in the world, a vaccine against the new coronavirus was registered in Russia

"This morning, for the first time in the world, a vaccine against the new coronavirus was registered in Russia." President Vladimir Putin said Russia's Health Ministry has given regulatory approval for the world's first COVID-19 vaccine after less than two months of human testing, President Vladimir Putin said on Tuesday. Putin added that the vaccine, developed by Moscow's Gamaleya Institute, has proven efficient during tests and promises to offer "sustainable immunity" against the coronavirus. "I would like to repeat that it has passed all the necessary tests,'' Putin said. "The most important thing is to ensure full safety of using the…
Read More